glp 1 questionnaire Rapid uptake of GLP-1 receptor agonists in patients with inflammatory bowel disease: a 14-month repeated cross-sectional survey A new Yale University study

That's our job as responsible scientists. It also remains unknown whether there will be any new side effects that pop up if people remain on these drugs for 30, 40, or 50-plus years

More about this Pin This photo was taken @NWORLD's manufacturing plant in South Korea

While the risk of hypoglycemia is low with GLP-1 receptor agonists alone, this risk increases when combined with insulin or sulfonylureas

FIGURE 2 3.1 Brain insulin resistance Insulin resistance in the brain perpetuates neuroinflammation, tau hyperphosphorylation, and amyloid pathology in AD and is therefore a driver of neurodegenerative disease (Hlscher, 2019)